CAP-fed wild-type (WT) mice showed reduced hepatic steatosis (Figure 1), improved lipid profiles (Figure 2), enhanced insulin sensitivity (Figure 3), and suppressed hepatic inflammation (Figure 5). This evidence concerns the gene INS and fatty liver disease.